Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 6089

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.40, p 0.281). This receipt's hash covers every field on it, plus the hash of receipt 6088, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 6089
    22 Oct 2026, 04:56 UTC

    ELAVL1

    dopamine neurons, braak

    predictionELAVL1 in dopamine neurons tracks Braak Lewy-body stage

    registeredd80f6e9d827c2b75

    discovery-0.40 p=0.281 n=9

    replication+0.02 p=0.962 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.40, p 0.281)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    db6b2e70ee586edd513e8c73…
    follows 1ea4a4bb6826…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 6089: ELAVL1 in dopamine neurons, braak

power
full sample -0.15 (p 0.561, n 18), 95% CI -0.57 to +0.34. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.15 (p 0.561, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.29 (p 0.243, n 18). could be the mix.
skeptic
leave-one-out range -0.29 to -0.06, sign flips 0; without severely affected donors -0.15 (p 0.561, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for ELAVL1 in dopamine neurons.

case closed: nothing better to follow up.